The immunological synapse as a novel therapeutic target

Current Opinion in Investigational Drugs

Volumn 7, Issue 11, 2006, Pages 1008-1013

  Teft, Wendy A ^a   Madrenas, Joaquín ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

CD28; Costimulation; Cytotoxic T lymphocyte associated antigen 4; Immunological synapse; Microcluster; T cell activation

Indexed keywords

ABATACEPT; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PEPTIDE;

ANTIGEN PRESENTING CELL; CELLULAR IMMUNITY; DOWN REGULATION; DRUG TARGETING; DRUG USE; EFFECTOR CELL; HUMAN; IMMUNOMODULATION; INTERNALIZATION; LIPID RAFT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; DRUG DESIGN; EPITOPES, T-LYMPHOCYTE; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 33751068207     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Germain RN, Stefanova, I. The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation. Annu Rev Immunol (1999) 17:467-522.
2. Chambers CA. The expanding world of co-stimulation: The two-signal model revisited. Trends Immunol (2001) 22(4):217-223.
3. Friedl P, den Boer AT, Gunzer M. Tuning immune responses: Diversity and adaptation of the immunological synapse. Nat Rev Immunol (2005) 5(7):532-545.
4. Groves JT, Dustin ML. Supported planar bilayers in studies on immune cell adhesion and communication. J Immunol Methods (2003) 278(1-2):19-32.
5. Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse. Annu Rev Immunol (2001) 19:375-396.
6. Bossi G, Trambas C, Booth S, Clark R, Stinchcombe J, Griffiths GM. The secretory synapse: The secrets of a serial killer. Immunol Rev (2002) 189:152-160.
7. Jacobelli J, Andres PG, Boisvert J, Krummel MF. New views of the immunological synapse: Variations in assembly and function. Curr Opin Immunol (2004) 16(3):345-352.
8. Brossard C, Feuillet V, Schmitt A, Randriamampita C, Romao M, Raposo G, Trautmann A. Multifocal structure of the T cell-dendritic cell synapse. Eur J Immunol (2005) 35(6):1741-1753.
9. Richie LI, Ebert PJ, Wu LC, Krummel MF, Owen JJ, Davis MM. Imaging synapse formation during thymocyte selection: Inability of CD3δ, to form a stable central accumulation during negative selection. Immunity (2002) 18(4):595-606.
10. Faroudi M, Utzny C, Sailo M, Cerundolo V, Guiraud M, Muller S, Valitutti S. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold. Proc Natl Acad Sci USA (2003) 100(24):14145-14150.
11. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol (2004) 5(5):524-530.
12. O'Keefe JP, Gajewski TF. Cutting edge: Cytotoxic granule polarization and cytolysis can occur without central supramolecular activation cluster formation in CD8+ effector T cells. J Immunol (2005) 175(8):5581-5585.
13. Lee KH, Dinner AR, Tu C, Campi G, Raychaudhuri S, Varma R, Sims TN, Burack WR, Wu H, Wang J, Kanagawaa O et al (2003) The immunological synapse balances T cell receptor signaling and degradation. Science 302(5648):1218-1222.
14. Depoil D, Zaru R, Guiraud M, Chauveau A, Harriague J, Bismuth G, Utzny C, Muller S, Valitutti S. Immunological synapses are versatile structures enabling selective T cell polarization. Immunity (2005) 22(2):185-194.
15. Campi G, Varma R, Dustin ML. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med (2005) 202(8):1031-1036.
16. Yokosuka T, Sakata-Sogawa K, Kobayashi W, Hiroshima M, Hashimoto-Tane A, Tokunaga M, Dustin ML, Saito T. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol (2005) 6(12)1253-1262.
17. Douglass AD, Vale RD. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell (2005) 121(6):937-950.
18. Giannoni F, Barnett J, Bi K, Samodal R, Lanza P, Marchese P, Billetta R, Vita R, Klein MR, Prakken B, Kwok WW et al Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C 6 translocation to the T cell plasma membrane. J Immunol (2005) 174(6):3204-3211.
19. Mossman KD, Campi G, Groves JT, Dustin ML. Altered TCR signaling from geometrically repatterned immunological synapses. Science 310(5751):1191-1193.
20. Monjas A, Alcover A, Alarcon B. Engaged and bystander T cell receptors are down-modulated by different endocytotic pathways. J Biol Chem (2004) 279(53):55376-55384.
21. Naramura M, Jang IK, Kole H, Huang F, Haines D, Gu H. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol (2002) 3(12):1192-1199.
22. Wedemann A, Muller S, Favier B, Penns D, Guiraud M, Delmas C, Champagne E, Valitutti S. T-cell activation is accompanied by an ubiquitination process occurring at the immunological synapse. Immunol Lett (2005) 98(1):57-61.
23. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity (2006) 25(1)117-127.
24. Harding CV, Unanue ER. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (1990) 346(6284)574-576.
25. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity (1996) 4(6):565-571.
26. Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM. Direct observation of ligand recognition by T cells. Nature (2002) 419(6909):845-849.
27. Wülfing C, Sumen C, Sjaastad MD, Wu LC, Dustin ML, Davis MM. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat Immunol (2002) 3(1):42-47.
28. Li QJ, Dinner AR, Qi S, Irvine DJ, Huppa JB, Davis MM, Chakraborty AK. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat Immunol (2004) 5(8):791-799.
29. Krogsgaard M, Li QJ, Sumen C, Huppa JB, Huse M, Davis MM. Agonist/ endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature (2005) 434(7030):238-243.
30. Yachi PP, Ampudia J, Gascoigne NR, Zal T. Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat Immunol (2005) 6(8):785-792.
31. Shaw AS, Dustin ML. Making the T cell receptor go the distance: A topological view of T cell activation. Immunity (1997) 6(4):361-369.
32. Dustin ML, Shaw AS. Costimulation: Building an immunological synapse. Science (1999) 283(5402):649-650.
33. Wulfing C, Davis MM. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science (1998) 282(5397):2266-2269.
34. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science (1999) 283(5402):680-682.
35. Meiri KF. Lipid rafts and regulation of the cytoskeleton during T cell activation. Philos Trans R Soc Lond B Biol Sci (2005) 360(1461):1663-1672.
36. Holdorf AD, Lee KH, Burack WR, Allen PM, Shaw AS. Regulation of Lck activity by CD4 and CD28 in the immunological synapse. Nat Immunol (2002) 3(3):259-264.
37. Tavano R, Gri G, Molon B, Marinari B, Rudd CE, Tuosto L, Viola A. CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes. J Immunol (2004) 173(9):5392-5397.
38. Burack WR, Lee KH, Holdorf AD, Dustin ML, Shaw AS. Cutting edge: Quantitative imaging of raft accumulation in the immunological synapse. J Immunol (2002) 169(6):2837-2841.
39. Bromley SK, Iaboni A, Davis SJ, Whitty A, Green JM, Shaw AS, Weiss A, Dustin ML. The immunological synapse and CD28-CD80 interactions. Nat Immunol (2001) 2(12):1159-1166.
40. Andrea PG, Howland KC, Dresnek D, Edmondson S, Abbas AK, Krummel MF. CD28 signals in the immature immunological synapse. J Immunol (2004) 172(10):5880-5886.
41. Sanchez-Lockhart M, Marin E, Graf B, Abe R, Harada Y, Sedwick CE, Miller J. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J Immunol (2004) 173(12)7120-7124.
42. Sanchez-Lockhart M, Miller J. Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription. J Immunol (2006) 176(8):4778-4784.
43. Baroja ML, Lorre K, Van Vaeck F, Ceuppens JL. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell Immunol (1989) 120(1):205-217.
44. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol (2006) 24:65-97.
45. Darlington PJ, Baroja ML, Chau TA, Siu E, Ling V, Carreno BM, Madrenas J. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. J Exp Med (2002) 195(10):1337-1347.
46. Chikuma S, Imboden JB, Bluestone JA. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J Exp Med (2003) 197(1):129-135.
47. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity (1996) 4(6):535-543.
48. Egen JG, Allison JP. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity (2002) 16(1):23-35.
49. Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, Jussif J, Baroja ML, Madrenas J. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol (2000) 165(3):1352-1356.
50. Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity (2004) 21(3):401-413.
51. Tseng SY, Liu M, Dustin ML. CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase C6 in the immunological synapse. J Immunol (2005) 175(12):7829-7836.
52. Vijayakrishnan L, Slavik JM, Illes Z, Greenwald RJ, Rainbow D, Greve B, Peterson LB, Hafler DA, Freeman GJ, Sharpe AH, Wicker LS, Kuchroo VK. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity (2004) 20(5):563-575.
53. Jansson A, Barnes E, Klenerman P, Haden M, Sorensen P, Davis SJ, Nilsson P. A theoretical framework for quantitative analysis of the molecular basis of costimulation. J Immunol (2005) 175(3):1575-1585.
54. Bhatia S, Edidin M, Almo SC, Nathenson SG. Different cell surface oilgomeric states of B7-1 and B7-2: implications for signaling. Proc Natl Acad Sci USA (2005) 102(43):15569-15574.
55. Darlington PJ, Kirchhof MG, Criado G, Sondhi J, Madrenas J. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation. J Immunol (2005) 175(2):996-1004.
56. Bluestone JA, St Clair EW, Turka LA. CTLA4Ig: Bridging the basic immunology with clinical application. Immunity (2006) 24(3)233-238.
57. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falomi A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC, Puccetti P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol (2002) 3(11):1097-1101.
58. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol (2001) 19:225-252.
59. Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, Subudhi SK, Zheng XX, Strom TB, Bluestone JA. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol (2003) 171(7):3348-3352.
60. Hunig T, Dennehy K. CD28 superagonists: Mode of action and therapeutic potential. Immunol Lett (2005) 100(1)21-28.
61. Dennehy KM, Elias F, Zeder-Lutz G, Ding X, Altschuh D, Luhder F, Hunig T. Cutting edge: Monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses. J Immunol (2006) 176(10):5725-5729.
62. Margulies DH. CD28, costimulator or agonist receptor? J Exp Med (2003) 197(8):949-953.
63. Madrenas J, Chau LA, Teft WA, Wu PW, Jussif J, Kasaian M, Carreno BM, Ling V: Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligand. J Immunol (2004) 172(10):5948-5956.
64. Molon B, Gri G, Bettella M, Gomez-Mouton C, Lanzavecchia A, Martinez AC, Manes S, Viola A. T cell costimulaton by chemokine receptors. Nat Immunol (2005) 6(5):465-471.
65. Trautmann A. Chemokines as immunotransmitters? Nat Immunol (2005) 6(5):427-428.
66. No authors listed. Can super-antibody drugs be tamed? Nature (2006) 440(7086):855-856.
67. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med (2006) 355(10):1018-1028.